CN Patent

CN101904820A — 槲皮素纳米混悬剂冻干组合物及其制备方法和应用

Assigned to Individual · Expires 2010-12-08 · 15y expired

What this patent protects

本发明涉及一种槲皮素注射用纳米混悬剂冻干组合物及其制备方法和应用。本发明槲皮素纳米混悬剂冻干组合物由槲皮素、表面活性剂和冻干保护剂组成，遇水再分散后，其粒径小于300nm。由本发明冻干组合物制成的可供静脉注射的注射剂不需使用任何有机溶媒，降低了刺激性，提高了疗效。本发明提供的槲皮素纳米混悬剂冻干组合物选用的辅料均为注射用辅料，组成简单，制备方法经济可靠，具备产业化生产前景。

USPTO Abstract

本发明涉及一种槲皮素注射用纳米混悬剂冻干组合物及其制备方法和应用。本发明槲皮素纳米混悬剂冻干组合物由槲皮素、表面活性剂和冻干保护剂组成，遇水再分散后，其粒径小于300nm。由本发明冻干组合物制成的可供静脉注射的注射剂不需使用任何有机溶媒，降低了刺激性，提高了疗效。本发明提供的槲皮素纳米混悬剂冻干组合物选用的辅料均为注射用辅料，组成简单，制备方法经济可靠，具备产业化生产前景。

Drugs covered by this patent

Patent Metadata

Patent number
CN101904820A
Jurisdiction
CN
Classification
—
Expires
2010-12-08
Drug substance claim
No
Drug product claim
No
Assignee
Individual
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.